July 18 (Reuters) - Telix Pharmaceuticals Ltd (TLX) :
- Q2 UNAUDITED TOTAL REVENUE OF US$124M
- UPGRADED REVENUE GUIDANCE FOR FY2024 WHICH IS NOW EXPECTED TO BE IN RANGE OF US$490M TO US$510M
(([email protected];))
News: TLX Telix Pharmaceuticals Posts Q2 Unaudited Total Revenue Of $124 Mln
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.54 |
Change
0.410(2.14%) |
Mkt cap ! $6.465B | |||
| Open | High | Low | Value | Volume |
| $19.20 | $19.54 | $19.15 | $9.471M | 489.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 1402 | $19.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.54 | 1904 | 14 |
View Market Depth
| Last trade - 12.57pm 22/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |